SANG
Sangoma Technologies Corp
$3.50
0.00%
$116.5M
No data for this timeframe.
Vol
Market Cap$116.5M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (80%)
Inst. Holders2 funds
Inst. Value$154.1K
Inst. Activity1 buys / 1 sells
SEC Reports1
Exchange Nasdaq·Sector Services-Computer Programming, Data Processing, Etc.·Inc. A6·CIK 0001753368·Prev Close $3.50
Recent Activity
Jun 4, 2026
SEC
Sangoma announced CFO Larry Stock's retirement effective June 30, 2026, with SVP of Finance Adrian Back appointed as Int
6-K — Impact 3/10
Inst.
BANK OF AMERICA CORP — NEAR_EXIT
9,600 shares ($58.1K)
Inst.
UBS Group AG — NEW
2,628 shares ($15.9K)
Price Targets
$4.00
+14.3% upside
Buy
Current $3.50
Low $4.00
Median $4.00
High $4.00
1 analysts
$4.00
$4.00
Analyst Ratings
2Strong Buy
6Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 14, 2026 | Canaccord Genuity | DOWNGRADE | Speculative Buy → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.07 ▼ -85.4% | $-0.09 — $-0.06 | -780% YoY | 5 |
| Next Q | $-0.05 ▼ -11.1% | $-0.05 — $-0.05 | 29% YoY | 1 |
| Current FY | $-0.20 ▼ -17.6% | $-0.20 — $-0.20 | -61% YoY | 1 |
| Next FY | $0.13 ▲ +285.7% | $0.13 — $0.13 | 165% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $99.9K | DOUBLED |
| BANK OF AMERICA CORP | $54.2K | NEAR_EXIT |
2 institutional holders with $154.1K total value (30,400 shares) as of 2025-Q4. Top holders: MORGAN, BANK.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 19,700 | $99.9K | 64.8% | DOUBLED +576.6% |
| 2 | BANK OF AMERICA CORP /DE/ | 10,700 | $54.2K | 35.2% | NEAR_EXIT -76.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 40,100 | 9,600 | -76.1% | $58.1K | 2025-Q2 |
| UBS Group AG | NEW | — | 2,628 | — | $15.9K | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 3,281 | 22,200 | +576.6% | $98.8K | 2025-Q1 |
| CITADEL ADVISORS LLC | EXIT | 12,191 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | NEW | — | 12,191 | — | $85.6K | 2024-Q4 |
| MORGAN STANLEY | ADD | 2,400 | 3,281 | +36.7% | $23.4K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 4,000 | 2,400 | -40.0% | $12.9K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 3.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (80% buy). Based on 10 analysts: 2 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$4.00 mean target
+14.3% upside
Buy (1.67)
$4.00 Low
$4.00 High
| Metric | Value |
|---|---|
| Current Price | $3.50 |
| Target Low | $4.00 |
| Target Mean | $4.00 |
| Target Median | $4.00 |
| Target High | $4.00 |
| # Analysts | 1 |
| Recommendation | Buy (1.67) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.07 | $-0.09 | $-0.06 | -780.0% | -85.4% | 0↑ 3↓ | $0.1B | -13.6% | 5 |
| Next Q 2026-09-30 |
$-0.05 | $-0.05 | $-0.05 | 28.6% | -11.1% | 0↑ 2↓ | $0.1B | 1.6% | 1 |
| Current FY 2026-06-30 |
$-0.20 | $-0.20 | $-0.20 | -60.5% | -17.6% | — | $0.2B | -13.6% | 1 |
| Next FY 2027-06-30 |
$0.13 | $0.13 | $0.13 | 165.0% | +285.7% | 0↑ 1↓ | $0.2B | 3.0% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.068 | |
| 7d ago | $-0.037 | -0.031 |
| 30d ago | $-0.037 | -0.031 |
| 60d ago | $-0.037 | -0.031 |
| 90d ago | $-0.037 | -0.031 |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 14, 2026 | Canaccord Genuity | DOWNGRADE | Speculative Buy | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| May 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Apr 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Mar 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Feb 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Jan 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.